MIRM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Mirum Pharmaceuticals Inc

NASDAQ | MIRM

73.13

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 26, 2025)

$3.76B

Market Cap

-

P/E Ratio

-0.84

EPS

$78.54

52 Week High

$36.88

52 Week Low

HEALTHCARE

Sector

MIRM Chart

Recent Chart
Price Action

MIRM Technicals

Tags:

MIRM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $255M
Total Revenue $337M
Cost Of Revenue $82M
Costof Goods And Services Sold $82M
Operating Income -$88M
Selling General And Administrative $191M
Research And Development $141M
Operating Expenses $343M
Investment Income Net -
Net Interest Income -$519K
Interest Income $14M
Interest Expense $14M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $24M
Income Before Tax -$87M
Income Tax Expense $1M
Interest And Debt Expense -
Net Income From Continuing Operations -$88M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$49M
Net Income -$88M

Revenue & Profitability

Earnings Performance

MIRM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $671M
Total Current Assets $393M
Cash And Cash Equivalents At Carrying Value $223M
Cash And Short Term Investments $223M
Inventory $22M
Current Net Receivables $78M
Total Non Current Assets $278M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $250M
Intangible Assets Excluding Goodwill $250M
Goodwill -
Investments -
Long Term Investments $13M
Short Term Investments $58M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $445M
Total Current Liabilities $127M
Current Accounts Payable $15M
Deferred Revenue -
Current Debt -
Short Term Debt $1.7M
Total Non Current Liabilities $319M
Capital Lease Obligations $9.7M
Long Term Debt $308M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $318M
Other Current Liabilities $110M
Other Non Current Liabilities $2.5M
Total Shareholder Equity $226M
Treasury Stock -
Retained Earnings -$644M
Common Stock $5K
Common Stock Shares Outstanding $48M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $10M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $24M
Capital Expenditures $993K
Change In Receivables -
Change In Inventory -$3.2M
Profit Loss -
Cashflow From Investment -$90M
Cashflow From Financing $18M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$88M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $255M
Total Revenue $337M
Cost Of Revenue $82M
Costof Goods And Services Sold $82M
Operating Income -$88M
Selling General And Administrative $191M
Research And Development $141M
Operating Expenses $343M
Investment Income Net -
Net Interest Income -$519K
Interest Income $14M
Interest Expense $14M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $24M
Income Before Tax -$87M
Income Tax Expense $1M
Interest And Debt Expense -
Net Income From Continuing Operations -$88M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$49M
Net Income -$88M

MIRM News

MIRM Profile

Mirum Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Mirum Pharmaceuticals, Inc., based in Foster City, California, is a biopharmaceutical innovator focused on developing advanced therapies for severe liver diseases. The company is advancing an impressive pipeline of novel treatment candidates aimed at addressing critical unmet medical needs within hepatology. With a robust commitment to clinical development and a patient-centric approach, Mirum positions itself as a promising opportunity for institutional investors looking to engage with transformative growth in the dynamic healthcare sector.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.53%
$33.18
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
HOOD
+10.92%
$128.20
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
INHD
-0.97%
$0.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
GOOG
-1.03%
$320.28
F
+0.45%
$13.25
TWOH
0.00%
$0.00
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
WLGS
-5.57%
$0.04
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.40%
$7.82
AFMD
-34.94%
$0.18
PFE
0.00%
$25.71
SMX
+250.80%
$61.04
CAN
+0.75%
$0.92
CRCL
+10.02%
$79.92
KWM
+13.63%
$0.75
APLD
+5.05%
$24.94
DNN
-0.19%
$2.55
SMCI
+1.07%
$32.83
BABA
+0.37%
$157.60
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
MSTR
+2.00%
$175.64
WBD
+0.50%
$24.00
AG
+12.65%
$15.22
NGD
+6.76%
$8.37
IREN
-1.32%
$47.81
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
KDLY
+7.20%
$0.49
T
+0.69%
$26.00
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
META
-0.41%
$633.61
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.53%
$33.18
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
HOOD
+10.92%
$128.20
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
INHD
-0.97%
$0.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
GOOG
-1.03%
$320.28
F
+0.45%
$13.25
TWOH
0.00%
$0.00
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
WLGS
-5.57%
$0.04
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.40%
$7.82
AFMD
-34.94%
$0.18
PFE
0.00%
$25.71
SMX
+250.80%
$61.04
CAN
+0.75%
$0.92
CRCL
+10.02%
$79.92
KWM
+13.63%
$0.75
APLD
+5.05%
$24.94
DNN
-0.19%
$2.55
SMCI
+1.07%
$32.83
BABA
+0.37%
$157.60
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
MSTR
+2.00%
$175.64
WBD
+0.50%
$24.00
AG
+12.65%
$15.22
NGD
+6.76%
$8.37
IREN
-1.32%
$47.81
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
KDLY
+7.20%
$0.49
T
+0.69%
$26.00
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
META
-0.41%
$633.61
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.